Royalty Pharma Ownership & Insider Activity

Royalty Pharma PLC

RPRXNASDAQ

$60.27

-0.69-1.13%

Últ. Act.: Oct 20, 7:08 AM

$60.27

-0.69-1.13%

Royalty Pharma (RPRX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.5% of shares outstanding. Institutional investors hold 65.5%. Over the past 90 days, insiders made 5 sales worth $13.0M.

Shares Outstanding

445.277M

Shares Float

439.127M

Insider Shares Owned

2.279M

Insider % Owned

0.5%

Institutional Shares Held

291.699M

Institutional % Held

65.5%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$13.0M total

Net Activity

Net Selling

Net Value (90d)

-$13.0M

Date	Insider	Title	Type	Shares	Price	Value
Oct 5, 2026	Marshall Urist	EVP, RESEARCH & INVESTMENTS	SELL	4.126K	$57.10	$236K
Sep 28, 2026	Marshall Urist	EVP, RESEARCH & INVESTMENTS	SELL	4.126K	$57.88	$239K
Sep 22, 2026	Christopher Hite	EVP & CHAIRMAN, PARTNERING	SELL	100.000K	$58.53	$5.9M
Aug 18, 2026	Christopher Hite	EVP & CHAIRMAN, PARTNERING	SELL	116.800K	$59.97	$6.0M
Aug 13, 2026	Terrance P Coyne	EVP & CFO	SELL	11.002K	$58.68	$646K
Jul 1, 2026	Marshall Urist	EVP, RESEARCH & INVESTMENTS	SELL	9.099K	$55.88	$508K
Jun 30, 2026	Christopher Hite	EVP & CHAIRMAN, PARTNERING	SELL	130.000K	$56.50	$7.3M
Jun 24, 2026	Marshall Urist	EVP, RESEARCH & INVESTMENTS	SELL	9.098K	$55.18	$502K
Jun 23, 2026	Christopher Hite	EVP & CHAIRMAN, PARTNERING	SELL	150.000K	$54.40	$8.2M
May 26, 2026	Terrance P Coyne	EVP & CFO	SELL	64.399K	$53.98	$3.5M
May 20, 2026	Marshall Urist	EVP, RESEARCH & INVESTMENTS	SELL	13.684K	$52.75	$722K
May 14, 2026	Marshall Urist	EVP, RESEARCH & INVESTMENTS	SELL	13.684K	$53.06	$726K
May 14, 2026	Gregory Norden	DIRECTOR	SELL	3.045K	$53.00	$161K
Apr 28, 2026	Terrance P Coyne	EVP & CFO	SELL	34.791K	$49.78	$1.7M